PrismSpy vs AdScout vs SocialPeta for Indian healthcare (2026): honest feature-by-feature comparison, pricing, geographic fit, and where each tool actually wins

PrismSpy vs AdScout vs SocialPeta for Indian healthcare is a fair comparison to make, and one buyers should make honestly. All three are competitor-ad intelligence tools that draw from public ad transparency surfaces. They serve different buyers, cover different geographies, and price for different purchasing power. This piece lays out the factual comparison — feature by feature, in a table you can screenshot for a procurement deck — and then does the harder work of writing an honest fit map. We built PrismSpy for Indian healthcare specifically, so this comparison is written from that vantage; but AdScout and SocialPeta are real products with real strengths, and the piece treats them accordingly. If you are evaluating tools to sit underneath your Meta ads engagement, read the comparison before signing a contract.

Why this comparison comes up in Indian healthcare procurement

Healthcare marketing teams in India are increasingly systematising competitor intelligence, and the shortlist that appears in most RFPs is a mix of one global horizontal tool, one APAC-strong tool, and one India-specific option. The three that most often show up are AdScout (global, English-first, horizontal), SocialPeta (global with strong APAC and mobile-app coverage), and PrismSpy (India-specific, healthcare-only). The temptation is to buy the biggest database or the most familiar brand; the correct question is which tool's buyer profile matches yours. Someone running a global consumer app has different needs from someone running a 12-city IVF chain in India.

Category overview — what each tool actually is

AdScout. A global competitor-ad intelligence platform covering 100+ countries with a strong horizontal database of Meta, YouTube, LinkedIn, and TikTok ads. Built for global brands, agencies, and creative teams looking for cross-market inspiration and campaign benchmarking. English-first product with translation layers for other markets. Typically priced from around $199/month at the entry tier (approximate — verify current pricing with vendor).

SocialPeta. A global ad-intelligence platform with particular depth in mobile app advertising and strong coverage across APAC markets. Massive raw ad database (widely reported at multiple billions of ads across platforms and history) and one of the largest creative libraries in the category. Widely used by mobile game and app publishers. Typically priced from around $300/month at the entry tier (approximate — verify current pricing with vendor).

PrismSpy. India-specific, healthcare-only competitor intelligence platform built by ICG. Tracks 75+ Indian healthcare brands across 30+ specialty clusters (IVF, dermatology, dental, hair transplant, aesthetic, hospital, paediatric, mental health, ENT, ophthalmology, orthopaedic, cardiology, oncology, wellness, and more), 2,150+ active ads, ₹50Cr+ aggregate ad spend visibility, 4,697 searchable ad inspirations, 1,197 tracked offers, 419 services catalogued. Daily refresh. Compliance signals for NMC Ethics Code 2026, ASCI Guidelines 2022, DPDP Act 2023, PC-PNDT Act 1994 and ART Act 2021. Standalone from ₹4,999/- per specialty vertical or bundled free inside HealthApex OS (₹14,999/-, 9 tools).

The feature-by-feature comparison table

Every number in the table is verified from PrismSpy's side and stated as "typical" or "approximate" for AdScout and SocialPeta because pricing and features change and buyers should verify with the vendor before contracting.

Meta Catalyst IQ Creative Scoring Matrix — every ad classified into Core Performer, Scalable, Getting Started, or Review with recommended action" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

Where PrismSpy wins for an Indian healthcare buyer

PrismSpy's wins are all in the same direction — depth inside a narrow perimeter. The Indian healthcare watchlist is curated, not buyer-assembled: 75+ brands are already tracked across 30+ specialty clusters on day one. The compliance layer is built in — NMC, ASCI, DPDP, PC-PNDT and ART Act signals are flagged on the creatives an operator reviews, which means a marketing lead is not accidentally benchmarking against a competitor ad that is heading for an ASCI reprimand. The refresh is daily rather than weekly, which matters in specialties where creative half-lives run three to six weeks.

The pricing is INR-denominated and calibrated for Indian healthcare margins — ₹4,999/- per specialty vertical is inside the discretionary budget of a mid-size clinic marketing lead, and ₹14,999/- for the full HealthApex OS bundle (9 tools including PrismSpy) makes the marginal cost of PrismSpy effectively negligible once the OS is chosen. The 4,697 ad inspirations and 1,197 offers in the database are already tagged by hook, format, language and specialty, which turns competitive research into a five-minute exercise rather than an all-morning one.

Where AdScout wins

AdScout wins on breadth. If you run a global consumer brand, a technology company advertising in ten markets, or an agency serving clients across geographies, AdScout's horizontal database and multi-platform coverage (Meta, YouTube, LinkedIn, TikTok, display) is genuinely useful. The English-first product is polished, the interface is mature, and the creative-inspiration library sourced from 100+ countries is a legitimate creative asset for global campaign work. LinkedIn ad coverage in particular is stronger than most competitors — useful for B2B marketing teams. If your competitor set is not primarily in India and your vertical is not primarily healthcare, AdScout is a defensible primary choice.

Where SocialPeta wins

SocialPeta's wins are in raw scale and mobile-app depth. The database is one of the largest in the category by ad count, which matters if your job is to browse creative inspirations across the widest possible corpus. APAC coverage is strong, including markets that global horizontal tools underweight. Mobile app advertising — user acquisition creative for games, utility apps and social apps — is a specialty where SocialPeta has an established position. If you are running a mobile-app UA team, a global gaming publisher, or a brand needing very deep APAC market read across horizontal verticals, SocialPeta is a serious tool. Its pricing (approximately $300/month at entry) reflects that positioning.

The India compliance signal layer and why global tools structurally lack it

The single largest structural gap between PrismSpy and either global tool is India-specific medical advertising compliance. NMC Ethics Code 2026 restricts outcome guarantees, ASCI Guidelines 2022 require substantiation for comparative and superlative claims, PC-PNDT 1994 restricts prenatal-diagnostic advertising, ART Act 2021 restricts fertility success-rate claims, and DPDP Act 2023 governs the personal-data perimeter around targeting inference. None of these frameworks exist in the same form outside India, so a horizontal global tool has no commercial reason to build the flagging logic for them.

What this means practically: a global tool will happily show an Indian healthcare marketing lead a competitor creative that contains an ASCI-violating claim and mark it "high performing" — no flag, no note, no context. The buyer, benchmarking against it, may end up producing derivative creative that inherits the compliance risk. PrismSpy's specialty is exactly this flagging, and it is not a feature that can be bolted onto a horizontal tool as an afterthought — it requires the tool's creative-scoring engine to be built with the Indian medical advertising perimeter as a first-class input.

Pricing — the honest picture for an Indian buyer

Every pricing comparison across borders needs a currency and purchasing-power caveat. PrismSpy at ₹4,999/- per specialty is roughly $60 per month at 2026 rates. AdScout's entry tier at approximately $199/month is roughly ₹16,600/- per month for a general database that is not verticalised to Indian healthcare. SocialPeta's entry tier at approximately $300/month is roughly ₹25,000/- per month for a much larger horizontal database that is likewise not verticalised.

The right way to think about pricing is not per-month absolute but cost per useful decision. If a horizontal tool costs three to five times more but delivers a fraction of the India-healthcare-specific decisions, the effective cost per decision on the horizontal tool is materially higher for this specific buyer profile. Conversely if the buyer is a global CMO whose decisions span twelve markets, the horizontal tool is cheaper per useful decision because PrismSpy's India-only depth does not serve most of the surface area.

Where each tool actually fits — the honest decision guide

Choose PrismSpy if you are an Indian healthcare marketing lead, agency, hospital marketing director, or specialty clinic owner running Meta ads (and Google ads) in India. Choose it as default if your competitor set is primarily Indian healthcare brands, your compliance perimeter includes NMC / ASCI / DPDP / PC-PNDT / ART Act, and your budget is INR-denominated. Choose it as a complement to a global tool if you are a global agency with an India healthcare book of business.

Choose AdScout if your work spans 5-plus countries, your primary need is global creative inspiration and cross-market benchmarking, and your competitor set is horizontal across industries. Choose it if LinkedIn ad coverage is important (it is stronger there than most competitors). Choose it as your primary if your India healthcare work is a small share of a larger horizontal portfolio.

Choose SocialPeta if you are running mobile-app user acquisition, you need the largest possible horizontal creative corpus for inspiration browsing, or your work concentrates in APAC across multiple verticals. Choose it if your primary category is mobile gaming, mobile apps, or high-volume horizontal advertising where the raw scale of the database is the point.

Run PrismSpy alongside a global tool if you are a mid-size or large Indian healthcare agency that occasionally works on non-healthcare or cross-border briefs. PrismSpy handles the healthcare-India core; the global tool handles the edge cases. The combined stack is meaningfully cheaper than trying to bend a global tool to serve the healthcare-India core.

Powered by PrismSpy — every competitor Meta ad, watched daily

ICG built PrismSpy because Indian healthcare Meta ad competition is invisible without it. 75+ Indian healthcare brands tracked, 2,150+ active ads catalogued, ₹50Cr+ aggregate ad spend visibility per month. Every competitor ad — creative, offer, hook, run-length — refreshed daily. It runs underneath every Meta ads and performance marketing engagement at ICG.

• Watchlist Dashboard — 30-75 competitors per specialty cluster (IVF / dermatology / dental / hair transplant / aesthetic / hospital), daily refresh.
• Comparative Insights — highest-quality ads, longest-running creatives (proven converters), top hooks, emerging offers.
• Offers Intelligence — 1,197 offers tracked, discount intensity by brand, value tier distribution.
• Service Cluster + Inspirations — 419 services tracked, 4,697 searchable ad inspirations by hook / language / format.

Standalone from ₹4,999/- per specialty vertical, or bundled free inside HealthApex OS (₹14,999/- flat, 9 tools). Book a 30-min PrismSpy walkthrough on WhatsApp — Rohit + Hanuman walk you through your specialty's competitive landscape.

angryturtle/01-listing-overview.png" alt="Angryturtle Listing Overview — GBP watchlist with per-listing status, category, sub-scores, action count for 143+ managed Indian healthcare listings" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

PrismSpy pairs naturally with Meta Catalyst IQ, ICG's account-side platform running 23+ Indian healthcare Meta accounts at ₹9.1Cr+ optimised spend per month and ₹1,581 blended CPL against a ~₹3,200 market benchmark. PrismSpy tells you what competitors are doing; Meta Catalyst IQ turns the intelligence into cost-efficient conversion inside your own accounts.

Related reading

• Healthcare Meta ad transparency in India — what you can and cannot see
• Competitor share of voice for healthcare Meta ads in India
• Healthcare Meta ads agency India — pillar guide
• IVF marketing agency India
• Dermatology marketing agency India
• Request a free healthcare Meta ads audit

FAQ

Q. Is PrismSpy trying to replace AdScout or SocialPeta?
No. PrismSpy replaces those tools only for the Indian healthcare buyer whose entire competitor set sits inside India and whose vertical is healthcare. For a global horizontal buyer, AdScout or SocialPeta remains the correct choice. For an agency straddling both, running PrismSpy alongside one global tool is the practical stack.

Q. Why is PrismSpy priced so much lower than AdScout or SocialPeta?
Two reasons. First, INR pricing versus USD pricing — the same absolute number lands differently in different purchasing power contexts. Second, PrismSpy's scope is deliberately narrow (India + healthcare), so the infrastructure and content-acquisition cost per user is a fraction of what a global horizontal tool has to carry. It is a specialty tool priced for a specialty market.

Q. Do global tools track Indian healthcare brands at all?
Yes, incidentally. AdScout and SocialPeta both pull from Meta Ad Library globally, so Indian healthcare brands appear in their databases if the buyer knows to search for them. What is missing is the curation (which 75 brands to watch inside each specialty), the clustering (30+ specialty groupings), and the compliance flagging (NMC / ASCI / DPDP / PC-PNDT / ART). Those layers are what turn raw ad data into a healthcare decision.

Q. What does PrismSpy not do that AdScout or SocialPeta does?
PrismSpy does not cover 100+ countries. It does not cover LinkedIn ads or TikTok ads as first-class surfaces (both are on the roadmap; today the focus is Meta + Google in India). It does not have the multi-billion-ad horizontal database SocialPeta carries. It does not have the horizontal-industry creative library AdScout is known for. For those needs, one of the global tools is the right choice.

Q. Can I trial PrismSpy before committing?
Yes. Rohit and Hanuman run 30-minute walkthroughs on WhatsApp where they demo your specialty's competitor cluster live. If the specialty is a fit, trial access follows. Book via the WhatsApp link in the PrismSpy section above.

Q. What is the daily-refresh advantage in practical terms?
In specialties like hair transplant where the creative refresh cycle is around three weeks and in aesthetic where seasonal offers move on a weekly cadence, a weekly refresh lags behind the actual market movement by half a cycle. Daily refresh means the operator sees the movement while it is still actionable rather than after the auction has already reset around it.

Q. Are AdScout's and SocialPeta's prices really $199 and $300 per month?
Those figures are the widely-reported entry-tier starting points as of publication and are marked approximate throughout this piece. Both vendors have multiple tiers, custom enterprise pricing, and periodic promotions. Confirm the current plan and pricing directly with each vendor before making a purchase decision.

Q. Does PrismSpy's pricing include implementation and training?
Yes for the HealthApex OS bundle — the ₹14,999/- flat covers all 9 tools including onboarding, dashboard set-up and training. For standalone PrismSpy at ₹4,999/- per specialty, onboarding is a 30-minute WhatsApp session and the interface is designed to be self-explanatory for a marketing lead. Enterprise implementations get a dedicated account manager.

For context on the underlying disclosure surfaces every tool in this category draws from, see Meta's Ad Library and the ASCI code that applies to Indian healthcare advertising.